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Hepatitis B virus (HBV) infection is a common cause
of liver disease throughout the world. Worldwide, it is
estimated that there are 350 million people with per-
sistent HBV infection. More than 75% of persistently
infected people are in Asia, with an estimated 100 mil-
lion in China; 12% and approximately 50 million are
in Africa [1]. Around 15–20% of adults in Taiwan are
chronically infected with HBV [2,3]. HBV infection can
progress from an asymptomatic persistently infected
status to chronic hepatitis B, cirrhosis and decompen-
sated liver disease and/or hepatocellular carcinoma.
Liver biopsy is the most accurate means of assessing
the stages of diffuse liver disease as early or advanced,
pre-cirrhotic, and cirrhotic. However, liver biopsy is
an invasive procedure with several contraindications
and the risk of complications such as pain, hemorrhage,
bile peritonitis, penetration of abdominal viscera, pneu-
mothorax and death [4]. The mortality rate associated
with needle biopsy has been estimated to be between
0.009% and 0.12% [4].
Cirrhosis can also be staged clinically. A reliable
system is the Child-Pugh (CP) classification, which 
is based on a clinical (degree of ascites and hepatic
encephalopathy) and laboratory assessment (values
for albumin, prothrombin time and bilirubin). The CP
classification can reasonably predict survival in many
liver diseases and predicts the likelihood of major com-
plications of cirrhosis such as bleeding from varices
and spontaneous bacterial peritonitis [5].
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The purpose of this study was to test the hypothesis that cirrhotic change of liver in hepatitis B
patients observed in Child-Pugh classification based on clinical assessment would be reflected in
the apparent diffusion coefficient (ADC) values calculated from diffusion-weighted magnetic
resonance (MR) imaging. Twenty-seven patients with hepatitis B Child-Pugh class A cirrhosis
and 10 control subjects were referred for measurement values of the liver on a 3.0-T MR unit. The
results revealed that ADCs were significantly lower in hepatitis B patients with Child-Pugh class
A compared with control subjects (p < 0.01). In conclusion, our preliminary study showed that
hepatitis B patients with Child-Pugh class A had reduced ADC values in liver vis-a-vis normal
subjects.
Key Words: diffusion-weighted imaging, hepatitis B, liver, magnetic resonance imaging
(Kaohsiung J Med Sci 2007;23:442–6)
Diffusion-weighted MRI of the liver in hepatitis B
Kaohsiung J Med Sci September 2007 • Vol 23 • No 9 443
Owing to the invasiveness of the biopsy proce-
dure and its associated possible complications, the
development of an alternative noninvasive method
to characterize the condition of the liver is highly
desirable. Diffusion is the thermally-induced motion
of water molecules in biological tissues, also referred
to as Brownian motion [6–8]. The microscopic motion
includes molecular diffusion of water and microcircu-
lation of blood in the capillary network (microperfu-
sion). The clinical utility of diffusion-weighted imaging
(DWI) of magnetic resonance has been established
for acute stroke. Recently, DWI has also been applied
to specific regions of the body to detect malignant le-
sions [9]. Several DWI applications have been reported
showing that apparent diffusion coefficient (ADC)
values vary in diffuse diseases such as cirrhosis and
in focal lesions [9–11].
In this retrospective study, DWI was applied to
hepatitis B patients and control subjects. The results
were compared with the CP class in order to determine
if this technique could be of diagnostic or prognostic
value for hepatitis B.
MATERIALS AND METHODS
The study protocol was approved by our institutional
review board. Twenty-seven patients diagnosed with
persistent hepatitis B (18 men, 9 women; age range,
23–84 years; mean age, 55.3±16.1 years) and 10 control
subjects (6 men, 4 women; mean age, 37.3 ± 8.4 years)
were recruited for this study. Persistent hepatitis B was
defined as the presence of hepatitis B surface antigen
(HBsAg) in the serum for 6 months or longer. All
hepatitis B patients were hepatitis C negative. Patients
with focal malignant lesions of the liver visible on
imaging procedures including ultrasound, computed
tomography (CT) or magnetic resonance imaging
(MRI) were excluded from the study. The CP classifi-
cation is based on a scoring system of 5 to 15; scores
of 5 and 6 are CP class A, scores of 7–9 indicate class
B, and 10–15, class C [5]. Applying the CP scoring sys-
tem to assess the severity of cirrhosis, all hepatitis B
patients were classified as CP class A. Control subjects
had no known liver disease.
MRI
Patients were examined with a 3.0-T superconducting
MR system (GE Medical Systems, Milwaukee, WI,
USA) with a standard body coil (GE Medical Systems).
All patients underwent DWI with a routine hepatic MR
protocol. The hepatic protocol included a T1-weighted
spin-echo (130 ms/1.4 ms, repetition time [TR]/echo
time [TE]; number of excitations [NEX], 1.0; 8 mm slice
thickness; 40 cm × 40 cm field of view [FOV]; 256 × 128
matrix), a T1-weighted dual fast gradient-recalled-
echo sequence (in-phase and out-of-phase sequences)
(120ms/2.1ms, TR/TE [in-phase]; 120ms/1.3ms, TR/
TE [out-of-phase]; flip angle, 60°; NEX, 1.0; 8 mm sec-
tion thickness; 40cm×40cm FOV; 256×128 matrix), and
a T2-weighted fast spin-echo sequence with spectral
fat saturation (2,000ms/86ms, TR/TE; NEX, 2.0; 8mm
section thickness; 40 cm×40 cm FOV; 512×256 matrix).
Two breath hold DWI sequences were performed with
the single-shot echo-planar imaging technique with
motion-probing gradients in three directions. The fol-
lowing parameters were used to acquire 20 sections
in a 24-second breath hold (two b values: 0 and 500 s/
mm2; 1,000 ms/61.1 ms, TR/TE; NEX, 1.0; 8 mm sec-
tion thickness; 40 cm × 40 cm FOV; 128 × 256 matrix)
and a T1-weighted gradient-echo sequence (3.7 ms/
0.908ms, TR/TE; flip angle, 10°) after dynamic injection
of 0.1 mmol per kilogram of body weight of gadopen-
tetate dimeglumine through a power injector at a rate
of 2 mL/sec.
Image analysis
Signal intensities (SI) were measured on the images
recorded in a homogeneous circular area (diameter,
1 cm; area, 3.1416 cm2) at the posterior inferior seg-
ment of the right hepatic lobe to avoid motion arti-
facts and artifacts from the great vessels. Quantitative
ADC maps were derived automatically on a voxel-by-
voxel basis by using commercially available software
(Advantage Workstation 4.0; GE Medical Systems).
The ADC was calculated with a linear regression
analysis of the function
S = S0 · e−b × ADC
where S is the signal intensity after application of the
diffusion gradient, b is the diffusion factor, and S0 is
the signal intensity at b = 0 sec/mm2.
Signal to noise ratios (SNRs) of liver on DWI were
calculated
SNR = S/SDnoise
where S is the signal intensity and SDnoise is the 
standard deviation of the background noise.
Kaohsiung J Med Sci September 2007 • Vol 23 • No 9444
F.O. Hsu, Y.Y. Chiou, C.Y. Chen, et al
Statistical analysis
Differences between the two sets of data were assessed
with Student’s t test. A p value < 0.05 was considered
significant.
RESULTS
The SNRs of DWI and ADC for the liver are summa-
rized in the Table. There was no significant difference
in the SNRs of DWI between the control subjects and
hepatitis B patients. For control subjects, the average
ADC was 1.68±0.11×10−3 mm2/sec. For the hepatitis B
patients with CP class A, it was 1.44 ± 0.19 × 10−3 mm2/
sec. The mean ADC value in hepatitis B patients with
CP class A was significantly lower than that in the
control subjects (p < 0.01).
DISCUSSION
Diffusion is the microscopic randomly translated mo-
tion of molecules, and water molecular diffusion can
be measured in vivo using DWI and an ADC [8]. In
many biological tissues, particularly those that have
regular, ordered microstructure, the diffusion coeffi-
cient depends on the direction along which it is mea-
sured. MRI can only measure differences directionally,
and dependent components must be measured sepa-
rately. However, the liver, unlike the brain and kidney,
has an isotropic diffusion pattern, probably due to its
randomly organized structure [12]. This indicates that
the use of multidirectional diffusion gradients is un-
necessary in hepatic diffusion studies. In this study,
we used DWI with motion-probing gradients in three
directions.
The average ADC value calculated for control
subjects in this study is in agreement with reported
values of 1.52 to 1.79 × 10−3 mm2/sec [10,13]. For the
hepatitis B patients with CP class A, the average ADC
value was significantly lower than that in the control
subjects, which correlates with lower ADC values for
liver cirrhosis [11,14,15]. This finding is attributable
to the progressive accumulation of an extracellular
fibrillary matrix (mainly type I and type II collagen),
which characterizes chronic liver disease of any etiol-
ogy and is most completely expressed in cirrhosis [16].
The deposit of collagen fibers “restricts” the motion
of the water molecules and therefore reduces ADC
values in cirrhotic liver.
Our study had some limitations. Firstly, the num-
ber of patients included in our study was relatively
small. Secondly, we only enrolled patients with class
A cirrhosis in our study instead of those with all
classes of liver cirrhosis. Therefore, the results are
only applicable to mildly severe cirrhotic patients. As
for class B or class C cirrhotic patients, we are unable
to draw conclusions as to whether or not the ADCs
would be even lower than that of class A patients.
The reason for why we did not recruit class B and
class C patients was that in our institute, we did not
have many patients with this condition. Third, high
spatial resolution and less distortion are desirable 
for DWI of the liver. Single-shot echo-planar imaging
DWI is limited in both features. Combining DWI
with superparamagnetic iron oxide, fluid-attenuated
inversion-recovery, and high-field and/or new devel-
oping sequences, such as multi-shot echo-planar imag-
ing DWI and propeller DWI, would push DWI of the
liver to the first-line imaging study in the near future
[9]. Therefore, further study with a larger sample size
and more variety of severity in cirrhotic patients will
be needed to give a conclusive opinion for that 
question.
In summary, our preliminary study showed that
hepatitis B patients with CP class A liver cirrhosis had
lower ADC values than control subjects without any
known liver disease. ADC measurement may have 
a good potential for correlation with CP classification
of viral hepatitis B.
ACKNOWLEDGMENTS
We are grateful to the Kaohsiung Municipal Hsiao-
Kang Hospital, Taiwan, for financial support (kmhk-
94-029).
Table. Signal to noise ratio (SNR) and apparent diffusion
coefficient (ADC) values (×10−3 mm2/sec) measured in
the liver of control subjects and hepatitis B patients with
Child-Pugh class A liver cirrhosis*
Control subjects Hepatitis B patients 
p
(n = 10) (n = 27)
SNR 146.29 ± 25.87 155.98 ± 31.84 > 0.05
ADC 1.68 ± 0.11 1.44 ± 0.19 < 0.01
*Data are presented as mean ± standard deviation.
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